• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A review of the clinical effectiveness of exercise therapy for intermittent claudication.

作者信息

Ernst E, Fialka V

机构信息

Department of Physical Medical Rehabilitation, AKH, University of Vienna, Austria.

出版信息

Arch Intern Med. 1993 Oct 25;153(20):2357-60.

PMID:8215739
Abstract

BACKGROUND

Intermittent claudication is both frequent and disabling. Conservative treatment consists of the elimination of risk factors, particularly smoking, drug treatment, and physical exercises. This review represents an attempt to define how effectively exercise prolongs the walking ability of claudicants.

METHODS

A computerized literature search was done to identify all controlled trials on the subject. In addition, other studies were admitted if they were in accordance with certain quality criteria.

RESULTS

Without exception, these studies showed that exercise can prolong the pain-free walking distance of claudicants. Even though this message seems uniform and convincing, one should point out that all trials are burdened with methodological flaws. The variability of increase in walking ability demonstrated in these studies is impressive and cannot be fully explained. A multitude of possible mechanisms could be involved in bringing about the clinical effect; at present it is impossible to define their relative importance.

CONCLUSIONS

The optimal exercise program should be supervised, performed regularly for at least 2 months, and of high intensity. Appropriate steps to guarantee patients' compliance must be taken. Even though many fundamental questions remain unanswered, it is justified to prescribe exercise therapy for intermittent claudication more generally than is realized in today's practice.

摘要

相似文献

1
A review of the clinical effectiveness of exercise therapy for intermittent claudication.
Arch Intern Med. 1993 Oct 25;153(20):2357-60.
2
Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication.左旋丙酰肉碱可提高监督性体育锻炼对间歇性跛行患者绝对跛行距离的治疗效果。
Angiology. 2008 Feb-Mar;59(1):84-9. doi: 10.1177/0003319707304567.
3
Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.监督下运动及气动足部和小腿加压对股浅动脉闭塞所致间歇性跛行患者步行能力的改善:一项随机对照试验
Eur J Vasc Endovasc Surg. 2005 Aug;30(2):164-75. doi: 10.1016/j.ejvs.2005.03.011.
4
Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?不平衡的风险因素会影响间歇性跛行患者体育锻炼的效果吗?
Minerva Cardioangiol. 2009 Apr;57(2):165-74.
5
Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.己酮可可碱治疗间歇性跛行:随机对照试验的荟萃分析
CMAJ. 1996 Oct 15;155(8):1053-9.
6
Local versus systemic mechanisms underlying supervised exercise training for intermittent claudication.间歇性跛行监督运动训练的局部与全身机制
Vasc Endovascular Surg. 2008 Aug-Sep;42(4):314-20. doi: 10.1177/1538574408314442. Epub 2008 Mar 4.
7
A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.一项针对间歇性跛行的监督运动计划的临床及成本效益的非随机对照试验。
Eur J Vasc Endovasc Surg. 2007 Feb;33(2):202-7. doi: 10.1016/j.ejvs.2006.08.005. Epub 2006 Dec 4.
8
Community trial of home-based exercise therapy for intermittent claudication.间歇性跛行家庭运动疗法的社区试验
Vasc Med. 2009 May;14(2):103-7. doi: 10.1177/1358863X08098596.
9
Predictors of walking distance after supervised exercise therapy in patients with intermittent claudication.间歇性跛行患者接受监督运动治疗后步行距离的预测因素。
Eur J Vasc Endovasc Surg. 2009 Oct;38(4):449-55. doi: 10.1016/j.ejvs.2009.04.020. Epub 2009 Jun 21.
10
[Methods and results of controlled walking training in patients with peripheral arterial occlusive disease].[外周动脉闭塞性疾病患者的控制性步行训练方法及结果]
Z Arztl Fortbild Qualitatssich. 1999 Nov;93(9):626-32.

引用本文的文献

1
Myonectin stimulates endothelial angiogenic activity in vitro and in vivo.肌连接蛋白在体外和体内均可刺激内皮细胞的血管生成活性。
Nagoya J Med Sci. 2025 May;87(2):285-294. doi: 10.18999/nagjms.87.2.285.
2
Prostanoids for intermittent claudication.用于间歇性跛行的前列腺素类药物。
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD000986. doi: 10.1002/14651858.CD000986.pub3.
3
Optimal management of peripheral arterial disease for the non-specialist.非专科医生对周围动脉疾病的优化管理
Ulster Med J. 2011 Jan;80(1):33-41.
4
Supervised exercise for intermittent claudication - an under-utilised tool.间歇性跛行的监督性运动——一种未充分利用的工具。
Ann R Coll Surg Engl. 2009 Sep;91(6):473-6. doi: 10.1308/003588409X432149. Epub 2009 Jun 25.
5
Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular disease.收缩骨骼肌中的代谢惰性:外周血管疾病药物干预的新方法。
Br J Clin Pharmacol. 2004 Mar;57(3):237-43. doi: 10.1046/j.1365-2125.2003.01989.x.
6
Intermittent claudication in older patients. Practical treatment guidelines.老年患者间歇性跛行。实用治疗指南。
Drugs Aging. 1999 Apr;14(4):247-59. doi: 10.2165/00002512-199914040-00002.
7
Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease.与冠状动脉疾病患者相比,外周动脉疾病患者接受的动脉粥样硬化危险因素治疗强度较低。
J Gen Intern Med. 1997 Apr;12(4):209-15. doi: 10.1046/j.1525-1497.1997.012004209.x.
8
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.口服奈呋胺酯。其药理学及治疗外周闭塞性动脉疾病的应用综述。
Drugs Aging. 1996 Apr;8(4):299-322. doi: 10.2165/00002512-199608040-00005.
9
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.己酮可可碱(氧代己酮可可碱)。对其治疗外周血管疾病和脑血管疾病疗效的综述。
Drugs Aging. 1995 Dec;7(6):480-503. doi: 10.2165/00002512-199507060-00007.